Doctor Dialer
AI-integrated HIPAA-secure telemedicine communications suite for doctor-patient interactions
Platform · Cloud SaaSCompany source
Company profile
About OpenEvidence
OpenEvidence is a medical AI platform that organizes and expands the world's collective medical knowledge for healthcare professionals. Founded on the principle of 'gold in, gold out,' the platform uses specialized AI models trained exclusively on peer-reviewed medical literature rather than the open internet, ensuring every answer is grounded in verifiable sources. The company has established official content partnerships with The New England Journal of Medicine (NEJM), JAMA and the JAMA Network, the National Comprehensive Cancer Network (NCCN), Cochrane Systematic Reviews, Wiley's portfolio of 400+ medical journals, and leading medical societies including ACC, ADA, AAFP, NORD, ACOG, AUA, AAO, and ACEP. As of 2025, OpenEvidence is actively used daily by over 40% of U.S. physicians across more than 10,000 hospitals and medical centers nationwide, with more than 25,000 verified U.S. doctors registering each month. The platform provides natural-language search capabilities that allow clinicians to access evidence-based recommendations, clinical guidelines, and peer-reviewed research at the point of care. OpenEvidence has expanded beyond search to include OpenEvidence Visits for clinical documentation and the AI-Integrated Doctor Dialer for HIPAA-secure telemedicine communications, messaging, faxing, and voicemail. The platform is free and unlimited for verified U.S. healthcare professionals and is available via web and mobile app.
Company description OpenEvidence official website
Primary marketGenerative AI & Healthcare Infrastructure
Commercial modelCommercial information available on request
Work at OpenEvidence?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cardiology
- dermatology
- endocrinology
- gastroenterology
- geriatrics
- hematology
- internal medicine
- neurology
- obstetrics
- oncology
- psychiatry
- rheumatology
Who it serves
- healthcare professionals
- hospitals
- medical centers
- physicians
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
February 2025: Multi-year content agreement with NEJM Group. November 2025: Licensing agreement with NCCN for oncology guidelines. March 2026: Strategic partnership with Wiley for 400+ journals including Cochrane. February 2026: Wide release of AI-Integrated Doctor Dialer with messaging, faxing, and voicemail capabilities.
Partnerships
Recorded partners
- American Academy of Family Physicians (AAFP)
- American Academy of Ophthalmology (AAO)
- American College of Cardiology (ACC)
- American College of Emergency Physicians (ACEP)
- American College of Obstetricians and Gynecologists (ACOG)
- American Diabetes Association (ADA)
- American Urological Association (AUA)
- Cochrane
- JAMA and JAMA Network
- Mayo Clinic
- National Comprehensive Cancer Network (NCCN)
- National Organization for Rare Disorders (NORD)
- NEJM Group
- Wiley
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
OpenEvidence
AI-powered medical search and clinical decision support platform for physicians
Platform · Cloud SaaSCompany source
OpenEvidence Mobile App
Mobile medical AI platform for healthcare professionals
Software · Cloud SaaSCompany source
OpenEvidence Visits
AI-powered clinical documentation and visit management system
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Rewriting the Narrative on the Oncology Care Model.JAMA · Apr 21, 2026
AI for cancer treatment information: Can academia stay in the game?Cancer cell · Mar 9, 2026
From Zero-Shot to Bedside: A Practical Playbook for Adapting Open-Source Large Language Models to Clinical Symptom Extraction.Proceedings of machine learning research · Jan 1, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
40% of U.S. physicians use platform daily
Physician adoption rate
10,000+ hospitals and medical centers
Healthcare facility reach
25,000+ verified U.S. doctors registering monthly
Growth rate
37 million minutes of doctor-patient care communications
Usage of Dialer and Visits suite
Fastest platform to surpass 100,000 verified doctor users
Adoption speed in medical industry history
U.S. Healthcare Professionals (telemedicine)
Doctor-patient telemedicine communications and clinical documentation
Approximately 37 million minutes of doctor-patient care communications and interactions powered by OpenEvidence Dialer and Visits
U.S. Physicians (aggregate)
Clinical decision support and medical search at point of care across 10,000+ hospitals and medical centers
Over 40% of U.S. physicians actively use OpenEvidence daily, with 25,000+ verified U.S. doctors registering each month
Mayo Clinic
Reducing physician time spent searching for and gathering clinical information
Physicians can spend less time searching for information and more time with patients by accessing multimedia and information from leading clinical journals
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from OpenEvidence
Recent articles published on OpenEvidence's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Generative AI & Healthcare Infrastructure
Companies providing generative AI platforms, large language models (LLMs), foundation models, or broad AI infrastructure specifically designed for healthcare applications. These companies serve multiple clinical use cases across the health system rather than focusing on a single clinical application or disease area.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.